Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
Mi-Ryung Han, Sug Hyung Lee, Jung Yoon Park, Hyosun Hong, Jung Yoon Ho, Soo Young Hur, Youn Jin Choi
Cancer Res Treat. 2020;52(3):779-788.   Published online 2020 Feb 28     DOI: https://doi.org/10.4143/crt.2019.700
Citations to this article as recorded by Crossref logo
Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
Giovanni Marchi, Anna Rajavuori, Mai T.N. Nguyen, Kaisa Huhtinen, Sinikka Oksa, Sakari Hietanen, Sampsa Hautaniemi, Johanna Hynninen, Jaana Oikkonen
Translational Oncology.2024; 39: 101814.     CrossRef
Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer
Ricardo Roque, Ilda Patrícia Ribeiro, Margarida Figueiredo-Dias, Charlie Gourley, Isabel Marques Carreira
Biology.2024; 13(2): 88.     CrossRef
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer
Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun Lee
Cancer Research.2024; 84(3): 468.     CrossRef
Liquid biopsy into the clinics: Current evidence and future perspectives
Myrto Boukovala, C. Benedikt Westphalen, Victoria Probst
The Journal of Liquid Biopsy.2024; 4: 100146.     CrossRef
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial
Bonnita Werner, Katrin M Sjoquist, David Espinoza, Sonia Yip, Garry Chang, Michelle M Cummins, Linda Mileshkin, Sumitra Ananda, Catherine Shannon, Michael Friedlander, Kristina Warton, Caroline E. Ford
Translational Oncology.2024; 43: 101914.     CrossRef
Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies
Margaret Y. Han, Erkut H. Borazanci
Frontiers in Oncology.2023;[Epub]     CrossRef
Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
Liu Xin, Yang Yue, Ren Zihan, Cui Youbin, Lu Tianyu, Wang Rui
Frontiers in Physiology.2023;[Epub]     CrossRef
Advances in application of circulating tumor DNA in ovarian cancer
Ting Xia, Chenyan Fang, Yaqing Chen
Functional & Integrative Genomics.2023;[Epub]     CrossRef
Minimal residual disease in solid tumors: an overview
Yarui Ma, Jingbo Gan, Yinlei Bai, Dandan Cao, Yuchen Jiao
Frontiers of Medicine.2023; 17(4): 649.     CrossRef
The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review
Zexi Allan, Sasha Witts, Jeanne Tie, Niall Tebbutt, Nicholas J. Clemons, David S. Liu
British Journal of Cancer.2023; 129(11): 1717.     CrossRef
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
Cyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sébastien Gouy, Amandine Maulard, Stéphanie Scherier, Claire Sanson, Ludovic Lacroix, Sophie Cotteret, Lea Mauny, François Zaccarini, E
Molecular Cancer.2023;[Epub]     CrossRef
Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan
Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad, Hasnain Ahmed Farooqui, Tabish Chawla, S. M. Adnan Ali
Molecular Biology Reports.2022; 49(2): 1341.     CrossRef
Ascites and Serial Plasma Circulating Tumor DNA for Predicting the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis
Xiaolin Pu, Zongyuan Li, Xiaoying Wang, Hua Jiang
Frontiers in Oncology.2022;[Epub]     CrossRef
Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
Bonnita Werner, Kristina Warton, Caroline E. Ford
Cancers.2022; 14(5): 1309.     CrossRef
Potential clinical utility of liquid biopsies in ovarian cancer
Jie Wei Zhu, Parsa Charkhchi, Mohammad R. Akbari
Molecular Cancer.2022;[Epub]     CrossRef
Whole-Exome Sequencing Reveals Clinical Potential of Circulating Tumor DNA from Peritoneal Fluid and Plasma in Endometrial Cancer
Hye-Yeon Ju, Jung Yoon Ho, Jun Kang, Soo Young Hur, Sejin Kim, Youn Jin Choi, Mi-Ryung Han
Cancers.2022; 14(10): 2506.     CrossRef
Circulating tumour DNA — looking beyond the blood
Ann Tivey, Matt Church, Dominic Rothwell, Caroline Dive, Natalie Cook
Nature Reviews Clinical Oncology.2022; 19(9): 600.     CrossRef
Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer
Xiaoxiang Jie, Ming Du, Meng Zhang, Xiayu Jin, Qingqing Cai, Congjian Xu, Xiaoyan Zhang
Experimental and Therapeutic Medicine.2022;[Epub]     CrossRef
Liquid biopsy: current technology and clinical applications
Mina Nikanjam, Shumei Kato, Razelle Kurzrock
Journal of Hematology & Oncology.2022;[Epub]     CrossRef
Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
Xiaosha Wen, Huijie Pu, Quan Liu, Zifen Guo, Dixian Luo
Cancers.2022; 14(24): 6025.     CrossRef
Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review
Christine Fribert Thusgaard, Malene Korsholm, Kristina Magaard Koldby, Torben A. Kruse, Mads Thomassen, Kirsten Marie Jochumsen
Gynecologic Oncology.2021; 161(3): 884.     CrossRef
Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer
Bonnita Werner, Nicole Yuwono, Jennifer Duggan, Dongli Liu, Catherine David, Sivatharsny Srirangan, Pamela Provan, Anna DeFazio, Vivek Arora, Rhonda Farrell, Yeh Chen Lee, Kristina Warton, Caroline Ford
Gynecologic Oncology.2021; 162(3): 720.     CrossRef
Prediction of the treatment response in ovarian cancer: a ctDNA approach
Mina Sharbatoghli, Somayeh Vafaei, Hamidreza Aboulkheyr Es, Mohsen Asadi-Lari, Mehdi Totonchi, Zahra Madjd
Journal of Ovarian Research.2020;[Epub]     CrossRef